Addex Therapeutics Ltd (ADXN) Earnings History
Annual and quarterly earnings data from 2006 to 2024
Loading earnings history...
ADXN EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ADXN Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -681.8% | 1746.0% |
| 2023 | 100.0% | -139.1% | -654.5% |
| 2022 | 100.0% | -741.0% | -1462.6% |
| 2021 | 100.0% | -531.7% | -526.4% |
| 2020 | 100.0% | -338.9% | -355.9% |
Download Data
Export ADXN earnings history in CSV or JSON format
Free sign-in required to download data
Addex Therapeutics Ltd (ADXN) Earnings Overview
As of May 8, 2026, Addex Therapeutics Ltd (ADXN) reported trailing twelve-month net income of -$6M, reflecting +150.0% year-over-year growth. The company earned $-6.49 per diluted share over the past four quarters, with a net profit margin of 1746.0%.
Looking at the long-term picture, ADXN's historical earnings data spans multiple years. The company achieved its highest annual net income of $7M in fiscal 2024, representing a new all-time high.
Addex Therapeutics Ltd is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($376M net income, 36.5% margin), INVA ($504M net income, 63.8% margin), PRAX (-$327M net income), ADXN has outperformed on profitability metrics. Compare ADXN vs ACAD →
ADXN Earnings vs Peers
Earnings metrics vs comparable public companies
ADXN Historical Earnings Data (2006–2024)
19 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $7M | +166.8% | -$3M | $8.40 | 1746.0% | -681.8% |
| 2023 | -$11M | +49.3% | -$2M | $-16.80 | -654.5% | -139.1% |
| 2022 | -$21M | -35.5% | -$11M | $-55.20 | -1462.6% | -741.0% |
| 2021 | -$15M | -19.4% | -$16M | $-54.00 | -526.4% | -531.7% |
| 2020 | -$13M | +13.0% | -$12M | $-57.60 | -355.9% | -338.9% |
| 2019 | -$15M | -798.6% | -$15M | $-67.20 | -535.0% | -528.6% |
| 2018 | -$2M | +49.9% | -$1M | $-8.47 | -27.2% | -23.6% |
| 2017 | -$3M | -4.2% | -$3M | $-30.00 | -656.2% | -647.1% |
| 2016 | -$3M | +25.1% | -$3M | $-33.60 | -18174.1% | -18059.9% |
| 2015 | -$4M | -136.9% | -$4M | $-46.80 | -10432.0% | -9597.6% |
See ADXN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ADXN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ADXN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonADXN — Frequently Asked Questions
Quick answers to the most common questions about buying ADXN stock.
Is ADXN growing earnings?
ADXN EPS is $-6.49, with earnings growth accelerating to +150.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-6M.
What are ADXN's profit margins?
Addex Therapeutics Ltd net margin is +1746.0%, with operating margin at -681.8%. Above-average margins indicate pricing power.
How consistent are ADXN's earnings?
ADXN earnings data spans 2006-2024. The accelerating earnings trend is +150.0% YoY. Historical data enables comparison across business cycles.